|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
14.02(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$197.54 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,742,072 |
2,404,472 |
3,519,952 |
3,608,378 |
Total Sell Value |
$699,894,249 |
$883,563,199 |
$1,155,800,595 |
$1,175,475,107 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
39 |
65 |
82 |
89 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Keating Ashley M. |
Director |
|
2024-02-28 |
4 |
S |
$405.00 |
$202,500 |
D/D |
(500) |
0 |
|
3% |
|
Keating Ashley M. |
Director |
|
2024-02-28 |
4 |
OE |
$54.99 |
$27,495 |
D/D |
500 |
500 |
|
- |
|
Troendle August J. |
CEO |
|
2024-02-28 |
4 |
S |
$404.13 |
$20,206,500 |
I/I |
(50,000) |
5,133,019 |
|
3% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-28 |
4 |
S |
$404.13 |
$20,206,500 |
D/D |
(50,000) |
5,133,019 |
|
3% |
|
Troendle August J. |
CEO |
|
2024-02-27 |
4 |
S |
$401.88 |
$20,094,000 |
I/I |
(50,000) |
5,183,019 |
|
3% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-27 |
4 |
S |
$401.88 |
$20,094,000 |
D/D |
(50,000) |
5,183,019 |
|
3% |
|
Keating Ashley M. |
Director |
|
2024-02-26 |
4 |
S |
$403.89 |
$202,147 |
D/D |
(500) |
0 |
|
3% |
|
Keating Ashley M. |
Director |
|
2024-02-26 |
4 |
OE |
$54.99 |
$27,495 |
D/D |
500 |
500 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-26 |
4 |
S |
$402.38 |
$22,906,689 |
D/D |
(56,928) |
5,233,019 |
|
3% |
|
Troendle August J. |
CEO |
|
2024-02-26 |
4 |
S |
$402.38 |
$22,906,689 |
I/I |
(56,928) |
5,233,019 |
|
3% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-23 |
4 |
S |
$400.32 |
$40,032,000 |
D/D |
(100,000) |
5,289,947 |
|
3% |
|
Troendle August J. |
CEO |
|
2024-02-23 |
4 |
S |
$400.32 |
$40,032,000 |
I/I |
(100,000) |
5,289,947 |
|
3% |
|
Troendle August J. |
CEO |
|
2024-02-22 |
4 |
S |
$395.98 |
$39,598,000 |
I/I |
(100,000) |
5,389,947 |
|
1% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-22 |
4 |
S |
$395.98 |
$39,598,000 |
D/D |
(100,000) |
5,389,947 |
|
1% |
|
Troendle August J. |
CEO |
|
2024-02-21 |
4 |
S |
$383.44 |
$13,808,441 |
I/I |
(36,012) |
5,489,947 |
|
-1% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-21 |
4 |
S |
$383.44 |
$13,808,441 |
D/D |
(36,012) |
5,489,947 |
|
-1% |
|
Carley Brian T |
Director |
|
2024-02-20 |
4 |
OE |
$26.44 |
$364,396 |
D/D |
13,782 |
21,595 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-20 |
4 |
S |
$386.39 |
$5,404,823 |
D/D |
(13,988) |
5,525,959 |
|
-1% |
|
Troendle August J. |
CEO |
|
2024-02-20 |
4 |
S |
$386.39 |
$5,404,823 |
I/I |
(13,988) |
5,525,959 |
|
-1% |
|
Medpace Investors, Llc |
10% Owner |
|
2024-02-16 |
4 |
S |
$391.75 |
$19,587,500 |
D/D |
(50,000) |
5,539,947 |
|
0% |
|
Troendle August J. |
CEO |
|
2024-02-16 |
4 |
S |
$391.75 |
$19,587,500 |
I/I |
(50,000) |
5,539,947 |
|
0% |
|
Mccarthy Cornelius P. Iii |
Director |
|
2024-02-08 |
4 |
OE |
$57.17 |
$269,271 |
D/D |
4,710 |
5,038 |
|
- |
|
Carley Brian T |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
103 |
7,813 |
|
- |
|
Kraft Robert O. |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
94 |
376 |
|
- |
|
Mccarthy Cornelius P. Iii |
|
|
2023-12-31 |
4 |
OE |
$0.00 |
$0 |
D/D |
82 |
328 |
|
- |
|
533 Records found
|
|
Page 2 of 22 |
|
|